dihexa clinical trial human dihexa human clinical trials 2026 Clinical Trials Day 2026: Why Is It Important to Celebrate It? Have you heard of the

A: The current body of research on Dihexa is primarily preclinical

73.5% of combination participants achieved a glycated hemoglobin level of 6.5% or less

The authors administered oral Dihexa to APP/PS1 transgenic mice (a standard amyloidopathy model of Alzheimers disease) and showed that brain AngIV levels were elevated relative to wild-type after Dihexa administration, that spatial learning and memory were restored on Morris water maze testing, that hippocampal neuronal density and synaptophysin protein expression were preserved, that astrocyte and microglial activation were reduced, and that pro-inflammatory cytokines (IL-1, TNF-) decreased while anti-inflammatory IL-10 increased

J Tissue Viability, 2011

Study Design Considerations Research protocols must specify exact dosing schedules and concentrations

Direct human dose-finding trials are limited